STAAR Surgical Company
STAA Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow STAA
STAAR Surgical Company (STAA) P/E ratio
As of 16 October 2026, STAAR Surgical Company (STAA) trades at a P/E ratio of 304×. Over the past ten years it has ranged from 0.0× (June 2026) to 1,540× (June 2018); the current reading is higher than 80% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 66.1× | 3.13% |
| FY2022 | 64.1× | (58.81%) |
| FY2021 | 156× | (77.03%) |
| FY2020 | 677× | 496.81% |
| FY2019 | 113× | (62.99%) |
| FY2018 | 307× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 410× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| KMTS Kestra Medical Technologies, Ltd. compare | n/m |
| AVR Anteris Technologies Global Corp. compare | n/m |
| AZTA Azenta, Inc. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| ANGO AngioDynamics, Inc. compare | n/m |
| LMAT LeMaitre Vascular, Inc. compare | 27.9× |
| ATRC AtriCure, Inc. compare | 259× |
| STAA STAAR Surgical Company | 304× |
| NNNN Anbio Biotechnology compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)